Bortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats.

PloS one

Volumn 8, Issue 10, 2013, Pages

  Li, Shuai ^a   Wang, Xuejun ^b   Li, Yifan ^b   Kost, Curtis K ^b   Martin, Douglas S ^b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; BORONIC ACID DERIVATIVE; BORTEZOMIB; PROTEASOME INHIBITOR; PYRAZINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL; AORTA; ARTICLE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HYPERTENSION; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; AORTA; BORONIC ACIDS; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HYPERTENSION; MALE; PROTEASOME INHIBITORS; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; VASCULAR CELL ADHESION MOLECULE-1;

MLCS; MLOWN;

EID: 84899976555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078564     Document Type: Article

References (0)